Indeed, while some studies show an association between over-expression of VEGF-A and poor CRC outcomes [53–55], others demonstrate that either VEGF-A has no significant prognostic value in CRC patients [42, 56–58] or it assumes prognostic relevance only in association with other factors [59, 60]. The gene discussed is VEGFA; the disease is colorectal carcinoma.